UTAH: Using Telemedicine to improve early medical Abortion at Home: a protocol for a randomised controlled trial comparing face-to-face with telephone consultations for women seeking early medical abortion
Introduction Early medical abortion (EMA) is a two-stage process of terminating pregnancy using oral mifepristone (a progesterone-receptor antagonist) followed usually 1–2 days later by sublingual, vaginal or buccal misoprostol (a prostaglandin analogue). There are no published randomised controlled...
Main Authors: | John Norrie, John Joseph Reynolds-Wright, Sharon Tracey Cameron |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/11/6/e046628.full |
Similar Items
-
Medical abortion for an early pregnancy
by: Peng-Hui Wang, et al.
Published: (2011-03-01) -
Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
by: Ellen R Wiebe, et al.
Published: (2020-01-01) -
Concurrent Use of Mifepristone and Misoprostol for Early Medical Abortion
by: Yiu-Tai Li, et al.
Published: (2006-12-01) -
Use of Mifepristone and Sublingual Misoprostol for Early Medical Abortion
by: Mau Lin, et al.
Published: (2006-12-01) -
Women’s experiences of having an early medical abortion at home
by: Brolin, Lina, et al.
Published: (2013)